立体化学
差向异构体
部分
生物合成
化学
对接(动物)
三萜
抗真菌
分子模型
二维核磁共振波谱
酶
生物化学
生物
医学
替代医学
护理部
病理
微生物学
作者
Zhi Cheng,Wei Wu,Yu Liu,Shuo Chen,Hongji Li,Xingchi Yang,Xiaofan Zhu,Xuxiang Chen,Lan Yan,Zhi-Yong Chu,Peng Sun
标识
DOI:10.1021/acs.jnatprod.3c00562
摘要
Ibrexafungerp, an inhibitor of fungal β-(1,3)-d-glucan synthase, represents the first new class of antifungals to be approved in the last 20 years. Ibrexafungerp is a semisynthetic derivative of the naturally occurring triterpene glycoside enfumafungin. In order to search for new analogues of enfumafungin and to probe its biosynthesis, we undertook a reinvestigation of
科研通智能强力驱动
Strongly Powered by AbleSci AI